TGM Medical, a subsidiary of China Kanghui Holdings, has received the US Food and Drug Administration (FDA) approval for its Helicon Hip System (HHS), Milestone Knee System (MKS) and related surgical instruments.
Kanghui provides proprietary orthopedic implant products in trauma and spine in China.
China Kanghui Holdings CEO Libo Yang said they are very pleased that their recent acquisitions not only have laid a strong foundation for their future growth but also provide them with strong momentum for 2012.
"With successful FDA approvals for TGM’s HHS and MKS, we are well-positioned to introduce these products this year to start our reconstructive joint segment," Yang said.